A phase Ib study of the anti-CD47 antibody magrolimab with the PD-L1 inhibitor avelumab (A) in solid tumor (ST) and ovarian cancer (OC) patients.

Nehal J. Lakhani, Kathleen N. Moore, Roy L. Maute et al.|Journal of Clinical Oncology|2020

Cited by 37